Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hila Elinav

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Infectious Diseases and Therapy|November 24, 2025
Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort StudiesAndrea Antinori, Yoshiyuki Yokomaku, Hila Elinav, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 31, 2018
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015Kamilla Laut, Leah Shepherd, Roxana Radoi, et al.
Open Forum Infectious Diseases|January 7, 2021
Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive PersonsAmanda Mocroft, Jens D Lundgren, Juergen K Rockstroh, et al.
Scientific Reports|November 22, 2025
Colostrum from MERS-CoV seropositive camels for MERS prophylaxis and SARS-CoV-2 infection, a placebo controlled randomized trialHagit Masika, Meir Cherniak, Yelena Britan-Rosich, et al.
AIDS (London, England)|July 18, 2020
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAmanda Mocroft, Lene Ryom, Cristiana Oprea, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
Plos One|August 25, 2015
A Population-Structured HIV Epidemic in Israel: Roles of Risk and EthnicityZehava Grossman, Boaz Avidor, Zohar Mor, et al.
Frontiers in Immunology|February 17, 2023
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgAMiri Stolovich-Rain, Sujata Kumari, Ahuva Friedman, et al.
Nature Microbiology|February 16, 2026
Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infectionStavros Bashiardes, Melina Heinemann, Lorenz Adlung, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Infectious Diseases and Therapy|November 24, 2025
Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort StudiesAndrea Antinori, Yoshiyuki Yokomaku, Hila Elinav, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 31, 2018
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015Kamilla Laut, Leah Shepherd, Roxana Radoi, et al.
Open Forum Infectious Diseases|January 7, 2021
Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive PersonsAmanda Mocroft, Jens D Lundgren, Juergen K Rockstroh, et al.
Scientific Reports|November 22, 2025
Colostrum from MERS-CoV seropositive camels for MERS prophylaxis and SARS-CoV-2 infection, a placebo controlled randomized trialHagit Masika, Meir Cherniak, Yelena Britan-Rosich, et al.
AIDS (London, England)|July 18, 2020
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAmanda Mocroft, Lene Ryom, Cristiana Oprea, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
Plos One|August 25, 2015
A Population-Structured HIV Epidemic in Israel: Roles of Risk and EthnicityZehava Grossman, Boaz Avidor, Zohar Mor, et al.
Frontiers in Immunology|February 17, 2023
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgAMiri Stolovich-Rain, Sujata Kumari, Ahuva Friedman, et al.
Nature Microbiology|February 16, 2026
Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infectionStavros Bashiardes, Melina Heinemann, Lorenz Adlung, et al.
Pageof 5